Laura Clague - Net Worth and Insider Trading
Laura Clague Net Worth
The estimated net worth of Laura Clague is at least $1 Million dollars as of 2024-10-31. Laura Clague is the Director of Genasys Inc and owns about 206,311 shares of Genasys Inc (GNSS) stock worth over $769,540. Laura Clague is also the CFO of Travere Therapeutics Inc and owns about 35,655 shares of Travere Therapeutics Inc (TVTX) stock worth over $624,319. Details can be seen in Laura Clague's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Laura Clague has not made any transactions after 2022-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Laura Clague
Laura Clague Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laura Clague owns 4 companies in total, including Travere Therapeutics Inc (TVTX) , Standard BioTools Inc (LAB) , and Genasys Inc (GNSS) among others .
Click here to see the complete history of Laura Clague’s form 4 insider trades.
Insider Ownership Summary of Laura Clague
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TVTX | Travere Therapeutics Inc | 2022-05-11 | Chief Financial Officer |
LAB | Standard BioTools Inc | 2018-10-30 | director |
GNSS | Genasys Inc | 2022-02-23 | director |
2010-08-23 | director |
Laura Clague Latest Holdings Summary
Laura Clague currently owns a total of 2 stocks. Among these stocks, Laura Clague owns 206,311 shares of Genasys Inc (GNSS) as of February 23, 2022, with a value of $769,540 and a weighting of 55.21%. Laura Clague also owns 35,655 shares of Travere Therapeutics Inc (TVTX) as of May 11, 2022, with a value of $624,319 and a weighting of 44.79%.
Latest Holdings of Laura Clague
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GNSS | Genasys Inc | 2022-02-23 | 206,311 | 3.73 | 769,540 |
TVTX | Travere Therapeutics Inc | 2022-05-11 | 35,655 | 17.51 | 624,319 |
Holding Weightings of Laura Clague
Laura Clague Form 4 Trading Tracker
According to the SEC Form 4 filings, Laura Clague has made a total of 2 transactions in Genasys Inc (GNSS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Genasys Inc is the sale of 13,716 shares on February 23, 2022, which brought Laura Clague around $43,068.
According to the SEC Form 4 filings, Laura Clague has made a total of 13 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Travere Therapeutics Inc is the sale of 2,200 shares on May 11, 2022, which brought Laura Clague around $47,322.
Insider Trading History of Laura Clague
- 1
Laura Clague Trading Performance
Laura Clague Ownership Network
Ownership Network List of Laura Clague
Ownership Network Relation of Laura Clague
Laura Clague Owned Company Details
What does Travere Therapeutics Inc do?
Who are the key executives at Travere Therapeutics Inc?
Laura Clague is the Chief Financial Officer of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Medical Officer Jula Inrig , director & Chief Executive Officer Eric M Dube , and Chief Financial Officer Christopher R. Cline .
Travere Therapeutics Inc (TVTX) Insider Trades Summary
Over the past 18 months, Laura Clague made no insider transaction in Travere Therapeutics Inc (TVTX). Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,823 shares made by Christopher R. Cline , a net sale of 9,089 shares made by William E. Rote , and a net sale of 9,089 shares made by Elizabeth E Reed .
In summary, during the past 3 months, insiders sold 117,969 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 117,969 shares. During the past 18 months, 150,147 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 150,147 shares.
Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Travere Therapeutics Inc Insider Transactions
Laura Clague Mailing Address
Above is the net worth, insider trading, and ownership report for Laura Clague. You might contact Laura Clague via mailing address: 370 Park Ranch Place, Escondido Ca 92025.